Ultracel Q Plus and Density HIFU in Korea: Cartridge Depths and Session Planning — A Complete Guide
Ultracel Q Plus and Density are Korean high-intensity focused ultrasound (HIFU) platforms used for non-surgical skin tightening, and what separates a good outcome from a disappointing one is usually cartridge depth selection and shot count rather than which device name appears on the brochure. Most international patients compare HIFU quotes on price and brand alone, which is the least informative comparison available. This guide explains how focused ultrasound produces tightening, what each cartridge depth is designed to reach, how clinics construct shot-count quotes, how a realistic course is planned, and which safety questions matter. It is general information for patients evaluating options, not a recommendation of any specific device.
How HIFU Works: Focused Ultrasound and Coagulation Points
HIFU devices focus ultrasound energy to a precise depth beneath the skin surface, raising temperature at that focal point enough to create small zones of thermal coagulation while leaving the overlying epidermis comparatively unaffected. Each of these zones is a discrete point rather than a continuous field, which is why treatment is described in shots rather than passes.
The intended biological response is twofold: immediate tissue contraction at the treated points, followed over subsequent weeks and months by a wound-healing and neocollagenesis response in the surrounding tissue. This is why practitioners describe HIFU results as developing gradually, with the fuller effect typically assessed around two to three months after treatment rather than immediately. It also explains why HIFU is generally positioned for mild to moderate laxity. Focused ultrasound tightens existing tissue; it does not remove skin, and where laxity is advanced a surgical approach may produce a change that no energy device can match.
Where Ultracel Q Plus and Density Sit Among Korean HIFU Platforms
The Korean market contains numerous HIFU systems. Ultracel Q Plus is a Korean-manufactured multi-modality platform that combines HIFU cartridges with radiofrequency microneedling in some configurations. Density is another Korean HIFU system marketed on faster shot delivery and a wider cartridge range. Both sit alongside the better-known imported and domestic platforms that international patients tend to hear about first.
Positioning claims in this category should be read carefully. Manufacturers differentiate on shot speed, cartridge options, cooling and comfort, and whether the system offers real-time imaging. Those are genuine engineering differences, but they do not translate into a reliable ranking of clinical outcome, because outcome depends heavily on operator assessment and energy delivery. There is little independent head-to-head trial evidence comparing specific commercial HIFU platforms, and patients should treat confident superiority claims as marketing. The more productive question at consultation is not which device the clinic owns but how the operator plans to use it on your anatomy.
Cartridge Depths and What Each One Targets
HIFU cartridges are specified by focal depth, most commonly expressed in millimetres. The depths in routine aesthetic use are approximately 1.5 mm, 3.0 mm and 4.5 mm, with some platforms offering additional intermediate or deeper options and dedicated body cartridges.
The 4.5 mm cartridge is intended to reach the superficial musculoaponeurotic system layer, the fibromuscular sheet that surgeons address in a facelift, and is generally used across the mid and lower face and along the jawline. The 3.0 mm cartridge targets the deep dermis and subdermal tissue and is often used more broadly across the cheek. The 1.5 mm cartridge reaches the superficial dermis and is used for finer work, including the periorbital region and perioral lines, where deeper penetration would be inappropriate.
A treatment plan that uses only one depth across the whole face is usually a plan built around convenience rather than anatomy. Conversely, applying a deep cartridge over thin tissue or over areas where superficial nerves run close to the surface carries real risk.
Why Depth Matching Matters More Than Brand
Skin and subcutaneous thickness vary substantially between individuals and between regions of the same face. A depth that reaches the SMAS in one patient may pass beyond it in another with less subcutaneous fat, delivering energy where it produces discomfort or fat atrophy rather than tightening. This is the single most important reason to prioritise operator assessment over device brand, and it is why a consultation that includes palpation and a region-by-region plan is more reassuring than one that quotes a package price immediately.
Shot Counts, Coverage and How Quotes Are Constructed
Clinics typically quote HIFU as a number of shots, or lines, for a defined treatment area. A full-face treatment might be quoted at several hundred shots distributed across depths, while a targeted jawline treatment uses far fewer. Because the price per shot varies and the included depths vary, two quotes with the same headline figure can represent quite different treatments.
To compare quotes meaningfully, ask for the breakdown: how many shots at each cartridge depth, which anatomical regions are covered, and whether the neck is included or priced separately. A quote of 300 shots delivered entirely at 3.0 mm is not equivalent to 300 shots split across 4.5 mm and 3.0 mm with a 1.5 mm periorbital pass. Also confirm whether the cartridge is new for your treatment, since cartridges have a finite shot capacity and energy delivery can fall off as they approach the end of their rated life.
Session Planning: Intervals, Course Length and Maintenance
HIFU is not usually structured as a rapid multi-session course in the way that injectable boosters are. Because the collagen response develops over months, many practitioners treat once and reassess at around three months rather than repeating at short intervals. Where a second treatment is planned, intervals of several months to a year are more typical, with maintenance annually or as the clinical picture requires.
For international patients this has a practical implication: HIFU fits a single-visit trip reasonably well, since there is minimal downtime and no requirement to return within weeks. It also means you will most likely assess your own result at home rather than in the clinic, so agreeing in advance how follow-up photographs and review will be handled remotely is worthwhile.
Sequencing HIFU with Other Treatments
HIFU is frequently combined with botulinum toxin, fillers or skin boosters. Sequencing matters: heat delivered over recently placed filler may affect the product, and practitioners differ on the intervals they prefer. Disclose any injectable treatment you have had, including dates and products, and ask the clinic to explain its sequencing rationale rather than accepting a same-day combination package without discussion.
Safety, Side Effects and Who Should Avoid It
Common and expected effects include transient redness, mild swelling, tenderness to touch and a temporary tingling or aching sensation in the treated area. These typically settle within days. Less common but recognised complications include prolonged nerve-related symptoms such as numbness or temporary weakness, bruising, and localised fat atrophy where energy has been delivered inappropriately.
Caution is generally advised in pregnancy, over active infection or inflamed lesions in the treatment area, and in patients with implanted electrical devices or metallic implants in the treatment field, depending on the manufacturer's guidance. Patients with significant skin laxity should be counselled that the achievable change may be modest. A clinic that discusses these limits openly is applying the standard of disclosure that bodies such as the Korean Medical Association and the Korean Society of Plastic and Reconstructive Surgeons expect.
What the Evidence Supports
Clinical literature indexed on PubMed reports measurable improvement in laxity parameters following microfocused ultrasound treatment across a number of studies, with generally favourable safety profiles and adverse events that are mostly transient. The overall picture supports HIFU as a reasonable option for mild to moderate laxity in appropriately selected patients.
The evidence does not support several claims commonly encountered in clinic marketing: that HIFU is equivalent to a surgical lift, that results are permanent, or that one branded platform is demonstrably superior to another. Study populations are often small, follow-up periods limited, and assessment methods variable. Treat any promise of a dramatic or lasting transformation from a single non-surgical session with scepticism.
Frequently Asked Questions
How soon will I see a result?
Some immediate tightening may be visible, but the effect attributed to collagen remodelling develops gradually. Most practitioners assess the outcome at around two to three months. Judging the result in the first week is premature in either direction.
Is HIFU painful?
Sensation varies by depth and region, and deeper cartridges over bone are typically the least comfortable. Clinics commonly use topical anaesthetic, oral analgesia or, in some cases, nerve blocks. Discuss comfort options in advance rather than during treatment.
How long do results last?
Reported duration commonly falls in the range of roughly one to two years, but this depends on baseline laxity, age and individual healing. HIFU does not stop ongoing age-related change, so any result is set against a moving baseline.
Can HIFU replace a facelift?
No. They address different problems. HIFU tightens existing tissue without removing skin. Where there is significant excess skin, a surgical approach addresses something a focused-ultrasound device cannot, and a clinic suggesting otherwise is overselling.
Before You Book
Ask for a written treatment plan that specifies cartridge depths, shot counts per depth, the regions covered, whether a fresh cartridge will be used, the operator's qualifications and experience with the specific platform, and how a complication would be managed after you return home. Compare quotes on that breakdown rather than on the headline price or the device name.
Sources consulted for this guide include the Korea Health Industry Development Institute, the Korean Ministry of Food and Drug Safety, the Korean Society of Plastic and Reconstructive Surgeons, and clinical literature indexed on PubMed. This article is general information and not medical advice; treatment decisions should be made with a licensed physician who has examined you.



Comments